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Clinicians do not want tp miss underlying serious pathology, but it is still unclear which red flags are 
relevant. We aimed to evaluate the origin and evidence on diagnostic accuracy of red flags for 
malignancy for management of low back pain (LBP) in primary care. We performed a comprehensive 
overview and searched the literature using snowballing techniques and reference checking for evidence 
on red flags endorsed in clinical guidelines for identifying patients with higher likelihood of malignancy. 
We selected studies including people with LBP without any restriction on study design. We extracted 
data on prevalence and diagnostic accuracy. Furthermore, we assessed the methodological quality of 
studies evaluating diagnostic accuracy. We identified 13 red flags endorsed in a total of 16 guidelines 
and 2 extra red flags not endorsed in any guideline. We included 33 publications varying from systematic 
reviews to case reports. The origin of many red flags was unclear or was sourced from case reports. The 
incidence of malignancy in patients presenting with LBP in primary care varied between 0% to 0.7%. 
Seven studies provided diagnostic accuracy data on red flags. We found 5 red flags with accuracy data 
from 2 or more studies, with 2 (“history of malignancy” and “strong clinical suspicion”) considered 
informative. In conclusion, the origin and diagnostic accuracy of many red flags endorsed in guidelines 
are unclear. A “history of malignancy” and “strong clinical suspicion” are the only red flags with 











Low back pain (LBP) remains a common condition with an estimated lifetime prevalence of about 80% 
[1,2]. In 1 to 5% of patients presenting with LBP to primary care, a serious underlying pathology might 
be the cause, which needs timely and accurate diagnosis [4]. Spinal malignancy is, however, rare with 
less than 1% of patients presenting to primary care with LBP found to have a malignancy (primary 
vertebral tumor or vertebral metastasis) [5.6] 
Clinicians are encouraged by guidelines for managing patients with LBP to screen for red flags that might 
indicate underlying serious pathology [7]. Most guidelines suggest that the presence of red flags justifies 
further investigation, mainly magnetic resonance imaging (MRI), but the threshold for testing is often 
unclear [8]. The Cochrane review “Red flags to screen for malignancy in patients with low back pain” 
evaluated diagnostic accuracy of suggested red flags and found that evidence for the use and 
recommendation of most red flags is weak. Without rigorous evidence on the diagnostic accuracy of red 
flags, this advice may be associated with unwanted side effects through unnecessary imaging (increase 
of radiation and health care costs), unnecessarily alarming patients (resulting in reduction of quality of 
life) and/or unnecessary treatment (including unnecessary surgery) [9]. 
A previous study demonstrated that 16 clinical guidelines for LBP, which recommended a total of 14 
different red flags (including elevated ESR (erythrocyte sedimentation rate) related to the identification 
of malignancy [10]. Most guidelines did not justify their choice of red flags with supporting data. 
Therefore, the purpose of this study was to present data on the prevalence of malignancy in patients 
presenting with LBP and to identify the (!) origin and rationale for endorsed red flags, (2) quality of 
research that has evaluated red flags, and (3) diagnostic accuracy of red flags endorsed in the various 
guidelines for the diagnosis of malignancy in patients presenting with LBP.  
 
 
2. Method  
2.1. Design: This article was to perform a systematic review of studies evaluating the origin and 
diagnostic accuracy of guideline-endorsed red flags for malignancy in patients with LBP.  
2.2. Search strategy: Two authors (APV, AD) independently searched for studies concerning people with 
LBP. Eligible studies included systematic and narrative reviews, diagnostic accuracy studies, cohorts, 
case control studies, and case-series considering red flags for malignancies. We searched the electronic 
databases (Medline and Cinahl using MESH terms (key words: low back pain, red flags, serious 
pathology)) from inception to on July 27, 2016. We also searched for references in the guidelines and 
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relevant articles found, and we performed reference checking and “snowballing” of landmark articles 
[11].  
2.3. Selection of red flags. We selected the 13 distinct red flags for malignancies (excluding elevated 
ERS), which were endorsed in the 16 guidelines for LBP [10]. We defined red flags as signs or symptoms 
collected in the clinical assessment signalling underlying serious pathology that requires attention 
(Merriam-Webster dictionary). 
2.4. Methodological quality. Two authors (AD, APV) independently assessed the methodological quality 
of all included studies that presented sensitivity or specificity data on the diagnostic accuracy of red 
flags using QUADAS-2 [12]. The QUADAS-2 consists of 4 key domains covering patient selection, index 
test, reference test and flow of patients through the study and timing of the index test(s) and reference 
standard. We assessed each domain in terms the risk of bias (RoB) and the first 3 domains also in terms 
of concerns regarding applicability. When studies scored low risk of bias on at least 2 RoB domains and 
unclear on the others, we considered these studies to have low RoB. When studies scored high on at 
least 1 RoB domain or all domains as unclear, we considered these studies to have moderate RoB. We 
considered that all other studies were to have high RoB.  
2.5. Data extraction. Two authors (AD, APV) performed data extraction. Discrepancies were discussed 
until consensus was reached. 
2.6. Analysis. We described prevalences of spinal malignancies in patients presenting with LBP and 
presented the 13 red flags in a table with findings about their origin and research evidence. In case we 
found additional red flags with data about diagnostic accuracy and the original authors regard this red 
flag as relevant (ie, the authors of the original studies stated that this red flag needs to be considered in 
patient care), we added them to the table.  
Next, we calculate sensitivities, specificities, and likelihood ratios (LRs) of the studies that provided data. 
We graded the overall quality of the evidence according to the guidelines of the GRADE working groups. 
The quality of the evidence is rated as “high” and downgraded when one or more of the following 
criteria are not met: design (>50% of the study population in studies of high or moderate RoB); 
indirectness (>50% of the study population not originating from primary care); inconsistency 
(unexplained inconsistency of sensitivity and specificity in 2 or more studies); impreciseness (wide 
confidence intervals [Cis]); or other biases such as publication bias or fatal flaw. We did not grade the 
evidence when only 1 study presented data. We identified potential clinically informative red flags by a 







3.2. Search results. The search resulted in 164 articles and checking the reference list of the 16 
guidelines and snowballing the landmark paper of Deyo & Diehl (1988) resulted in 26 references. Full 
text screening was done on 63 references, which were judged relevant based on title and abstract. 
Finally, we included 33 articles, see flow chart (figure 1). Of the 26 references found using snowballing, 6 
studies, all case reports, were judged relevant. 
We found two systematic reviews presented in 5 articles [13-17]. Furthermore, we found 2 narrative 
reviews [10,18], 7 prospective cohort studies [19-26], 9 retrospective cohort studies often collecting 
data from medical records [27-35], and 8 case reports [36-43]. Six studies provided diagnostic test 
accuracy data related to red flags for detection of malignancy for patients with LBP and were included in 
the assessment of diagnostic accuracy using the QUADAS-2 (Table 1)[20,21,22,24,26,29]. 
 
3.2. Prevalence  
The prevalence of spinal malignancies in patients with LBP seemed to be influenced by setting. The 
prospective primary care cohort studies (4 studies; 4864 participants) reported prevalences of 
malignancy in patients with LBP between 0% to 0.6 - 0.7% [19/20,22,24,25]. Cohorts studies of 
radiographic reports (3 studies; 2981 participants) from patients referred from primary care reported 
prevalences between 0.2% and 7.0% [28,31,34]. One retrospective cohort study in tertiary care (n = 
1109 participants) found a prevalence of 5.9% [32].  
A narrative review reported that most spinal malignancies were the result of metastases of primary 
tumours in the body, mainly from breast, lung or prostate cancer [18]. The review reported that just 
20% of metastatic cancers appear in the lumbar spine; however, there was no reference to support this 
statement [18]. However, a descriptive study of 322 patients with cancer showed that most patients had 
lumbar metastasis, and in 32% of patients the primary cancer was breast cancer [27]. 
 
3.3. Origin of red flags  
The earliest report on red flags we located was by Thomas D Luke who reported red flags for spinal 
malignancies in 1911 [36]. He described 3 cases of women (age 50-61) with night pain and difficulties in 
walking/getting out of bed. Two women previously had a malignant breast cancer and all 3 women were 
in a “running down condition”, and died within a few weeks or months after first consultation. His final 
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recommendation was: “If there is severe pain at night running around the intercostal nerves to the front 
with inability to turn and a giving way of one or other leg on standing, one would be inclined to suspect 
spinal new growth. The previous existence of a breast tumour of malignant character is of great help . . . 
otherwise the difficulty of making an accurate diagnosis is undoubtedly very much greater.” [36]. This 
report is potentially the origin of the red flags ‘night pain’ and ‘previous history of cancer’. 
We found two case series reporting red flags related to malignancy. One presented 14 cases of people 
referred to a tumour centre with pelvic cancer [37]. Based on the 14 patients the authors suggest to be 
alert when patients (age > 45 years) have ‘insidious onset of pain without a trauma’, ‘> one month 
duration of complaints’, ‘progressive pain’, ‘night pain’, ‘malaise’ and ‘anorexia’. Another study 
presented 2 patients who consulted a chiropractor for back pain in an outpatient facility [38]. Both 
patients received chiropractic care for 4 to 9 weeks and initially both patients responded positive to the 
treatment, but they returned within a couple of months with comparable complaints. Finally, both 
received extensive work-up (plain radiographs, MRI, CT-scans and blood work) when they were 
eventually diagnosed with malignancy. No red flags were apparent during the first visit.  
We found five case reports. Patients were a 69-year-old man that visited a chiropractor with LBP after a 
twisting movement [39]; a 73-year-old lady with LBP and severe band like pain in the abdomen referred 
to a spine centre [40]; a 48-year-old women referred to physiotherapy for LBP [41]; a 15-year-old girl 
who visited the paediatric emergency department [42] and a 54-year-old man consulting the 
physiotherapist complaining of LBP after a motor vehicle accident [43]. In all cases, history taking and 
clinical examination did not reveal red flags that warranted medical referral. In addition, plain 
radiographs often showed no pathology, and treatment showed some benefit although for a short 
period. The main reason in all cases to order imaging and blood tests was progressive complaints within 
2 to 6 weeks.  
 
3.4. Studies without accuracy data  
One study was a secondary analysis of randomised clinical trial data [23]. Patients with an episode of 
back pain were included and ‘familiarity of LBP’ was evaluated as an indicator for serious pathology. One 
(out of 1190) participant had a malignancy (metastasis of breast cancer), but it was unclear whether this 
participant was positive on the red flag or not.  
Another study evaluated whether bone scintigraphy could identify occult malignancy in patients with 
musculoskeletal pain without a history of malignancy [28]. In this retrospective cohort of 491 patients, 
52% of them had mid- or lower back pain. In total, 30 patients (out of 491) as having a malignancy; all 
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but 1 were older than 50 years. Of all 310 patients older than 50 years, 158 had complaints of mid- or 
lower back pain of which 13 had malignancy. Unfortunately, we were unable to calculate the false 
negative and true negative proportions in patients with LBP (younger than 50 years of age), so no 
accuracy data on ‘age >50 years’ are presented.  
One study retrospectively evaluated patients referred to a spine centre to determine whether ‘lack of 
pain’ and ‘no limitation in range of motion during the physical examination’ were associated with 
malignancy [32]. They found 66 (out of 1109) patients to have metastatic bone cancer. Statistical testing 
revealed that these 66 patients weighted less, were more depressed or anxious, and more often had a 
scoliosis than the participants without malignancy (p < 0.05). ‘No pain during all four movements’ 
showed a sensitivity of 55% (95%CI 42 - 67%) and a specificity of 59% (95%CI 56 - 62%). As the authors 
did not regard this a valid red flag nor is it endorsed in any guideline, it was not included in table 1.  
Another study aimed to identify risk factors for serious pathology in patients with non-traumatic LBP 
visiting an emergency department [33]. They retrospectively examined health records on serious 
pathology within 30 days after the visit. In a cohort of 329 patients with LBP, 22 cases of serious 
pathology were found. No data on malignancy separate were presented. 
Recently, a study of health insurer data described the diagnosis of adolescents (10 – 19 years old) with 
LBP [35]. Within the PearlDriver Patient Record database, they found 215,592 adolescents with LBP and 
data of a final diagnosis within 1 year. In total 253 patients (0.1%) were diagnosed with a tumour over a 
10-year period. No data on signs and symptoms are presented.  
Lastly, a primary care prospective cohort included 669 patients with LBP of 55 years or older [25]. After a 
12-months follow-up 4 patients were found with malignancy, but no data on the diagnostic accuracy of 
red flags for malignancy were reported. 
 
3.5. Studies with accuracy data. 
Deyo and Diehl undertook the earliest study found evaluating the diagnostic accuracy of possible red 
flags for malignancy in patients presenting with LBP in primary care [19/20]. At first, they established a 
prospective cohort with the aim to evaluate X-ray utilisation in patients with LBP (n=621) visiting a walk-
in clinic between March 1982 and May 1983 [19]. They assessed 65 history and physical examination 
items and collected data regarding use of X-ray imaging. Because they found some patients with 
malignancies, they extended this cohort and included patients with LBP until September 1984 (n= 1975) 
[20]. Finally, 13 (0.7%) patients were identified as having malignancy 6 months after inclusion. Of these 
13 cases, 10 were over 50 years old, 4 had a history of cancer, 3 suffered from unexplained weight loss, 
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and 6 cases had no specific signs or symptoms. Furthermore, there were 34 other patients who also had 
a history of cancer but no malignancy was found. The authors divided the patients into the ones that 
had a malignancy (n=13) and the ones without (n=1962). Four items from history taking appeared to be 
significantly more common (prevalent) in patients with malignancy compared to the ones that had not: 
‘age ≥ 50 years’, ‘previous history of cancer’, ‘sought medical care in the past month (not improving)’ 
and ‘duration of episode > 1 month’. Last, they developed a discriminant rule using multivariable 
analysis and ‘a history of cancer’ and an ‘elevated ESR rate’ correctly classifying 97% of the patients [20]. 
No accuracy data were presented on the discriminant rule. 
In 1987, Frazier et al replicated this study in a retrospective cohort of 471 patients that visited a walk-in 
clinic with acute low back pain [29]. The authors stated: “The study was not intended to validate 
whether either the selective criteria or the clinic physicians' actual roentgenogram use correctly 
identified patients with serious causes of acute LBP.” X-rays were taken for 99 patients at initial visit, 
which revealed one patient with a metastasis of the prostate.  
Two more recent replication studies were conducted [24,25]. One prospective cohort study included 
1172 patients with a new episode of LBP in primary care [24]. After a 12-months follow-up, none of the 
patients was diagnosed with a malignancy, although the 9 red flags evaluated had false positive rates 
ranging from 0.1% to 24.0%. For example, 202 patients (17.2%) had an ‘insidious onset, 46 patients 
(3.9%) had ‘a history of cancer’, and 3 (0.3%) had ‘unexplained weight loss’. The other study did not 
present accuracy data and is described above [25]. 
We found three other prospective cohort studies [21,22,26]. One study was performed at an emergency 
department, aiming to evaluate the reasons for clinicians to order spinal radiographs [21]. Of the 482 
patients in the study, 458 (92%) reported LBP of which 7 patients (1.5%) were diagnosed with 
malignancy. All 7 patients were ‘60 years or older’ and had ‘a history of malignancy’. The clinicians were 
asked to state whether the patients had a ‘suspected clinical diagnosis’ of malignancy, but the diagnostic 
criteria for this clinical diagnosis are unclear. A malignancy was suspected in 20 patients but was 
confirmed by radiographs in only 3 of them.  
The second study examined in a primary care cohort (n=1030) the diagnostic value of anteroposterior 
views on X-rays for serious pathology with the aim to ‘safely omit it from examination without 
compromising diagnostic precision’ [22]. In total, 886 (86%) patients had LBP as the main complaint. 
They found 1 case of malignancy on anteroposterior radiographs (it was unclear if the patient had LBP), 
whereas 20 patients were suspected to have a malignancy (suspected clinical diagnosis).  
The third study was performed in secondary care setting aiming to describe the characteristic and MRI 
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findings of patients with LBP referred to an MRI center [26]. A total of 638 patients were included, of 
which 5 were diagnosed with a malignancy. Five red flags were evaluated: ‘age > 50 years’ (all 5 
patients), ‘continuous back pain’ (0 patients), ‘back pain at night’ (2 patients), ‘history of malignancy’ (1 
patient) and ‘unexplained weight loss’ (0 patients).  
Finally, we found 2 systematic reviews evaluating the diagnostic accuracy of possible red flags for 
malignancy [13,15]. The first review was one of the first assessing the methodological quality of the 
included studies and could be considered a state-of-the-art review at that time [13]. This review 
included 8 studies including the landmark paper [20]. The other 7 studies evaluated red flags in patients 
with known cancer and their association with having spinal metastasis. Most of the studies did not 
explicitly mention (L)BP as main complaint. One study included 322 patients with known spinal 
metastasis in a hospital setting explicitly reported that in 36% of patients there was no accompanying 
LBP [27]. The review found ‘sciatica’ (history item) and ‘spinal tenderness’ (during physical examination) 
to be the most prominent factors related to the existence of vertebral metastasis, i.e. these are not red 
flags for malignancy in people with LBP. Spinal tenderness has been evaluated as a sign to detect 
vertebral cancer in hospital based patients with cancer varied in sensitivity between 54% and 80% 
(specificity 70% –78%), but this context is very different to screening for malignancy in primary care 
patients with LBP. When used to detect malignancy in patients with LBP in primary care its diagnostic 
accuracy is disappointingly low (sensitivity: 15%; specificity: 60%; LR+ <1) [13,20].  
The second systematic review evaluated the diagnostic accuracy of all possible red flags as reported in 8 
studies, including the cohort of Deyo & Diehl, but this cohort was regarded as 2 separate studies (1986 
and 1988) [15]. All of the included studies are presented above.  
 
3.6. Methodological quality 
Three cohort studies in primary care were considered at low RoB (see figure 1) [20,24,26], 2 studies in 
secondary care were considered at moderate RoB, mainly because the reference standard was assessed 
with clear knowledge of the index tests results [21,22]. One retrospective cohort was regarded as of 
high RoB [29]. Only 1 study was clearly designed to assess diagnostic accuracy of red flags [24], all others 
were designed for another study question, but data about diagnostic accuracy could be extracted.  
 
3.7. Diagnostic accuracy 
Table 1 presents the 13 red flags as endorsed in the various guidelines and 2 additional red flags, of 
which the original authors regarded these flags as relevant.  
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For 5 red flags reported in one or more guidelines, we could not determine their origin or locate any 
diagnostic accuracy data (table 1). For the red flags not endorsed by the guidelines, one originated from 
the first prospective primary care cohort [20] and one from a case series [36].  
Seven red flags were evaluated in more than 1 study, of which 2 were found clinically informative. They 
were ‘history of malignancy’ (moderate quality evidence; LR+ = 6.4-15.3) and ‘strong clinical suspicion’ 




4. Discussion  
The prevalence of spinal malignancies in patients with LBP seemed to be influenced by setting and varies 
between 0% and 0.6% to 0.7% in primary care up to 0.2% and 7% in hospital settings. We found 13 red 
flags for malignancy endorsed in the 16 guidelines. For 5 of the red flags for malignancy the origin was 
unclear, and very limited diagnostic evidence was available for most guideline-endorsed red flags. The 
bulk of the evidence on red flags is provided by 2 studies considering a total of 3147 primary care 
patients [20,24]. Both studies were at low RoB and so can be considered as the best evidence on 
diagnostic accuracy of red flags in patients with LBP in primary care.  
Two red flags (‘history of malignancy’ and ‘strong clinical suspicion’) show potential in identifying 
patients with a higher likelihood of malignancy as they have sufficiently high LR+. Five other red flags 
(‘unexplained/unintentional weight loss’, ‘atypical pain’, ‘older age’, ‘failure to improve with treatment’ 
and ‘duration of complaint > 1 month’) have quite modest LR+ and would not assist clinical decision 
making, given the low prevalence of malignancy in primary care. The fact that 1 red flag (‘duration of 
complaint > 1 month’) is not endorsed in any of the guidelines appears justified by the accuracy data. 
We were unable to draw conclusions on 7 red flags, of which 5 we were unable to find any information 
at all. 
Atypical pain was a red flag with a range of definitions (including ‘increasing pain at night’, ‘pain not 
eased by a prone position’, continuous pain at rest’, ‘thoracic pain’ and ‘pain not worsened during 
movement’) was endorsed in 12 guidelines. The first mention of the importance of pain was the study 
by Thomas Luke [36]. This study stated that “pain at night running around the intercostal nerves to the 
front”, which might be the origin of ‘thoracic pain’ as a red flag in some of the guidelines. Actually, the 
factors stated by Thomas Luke in 1911 are endorsed by most guidelines. We found just 1 study from 




4.1. Comparison with other literature 
Where the Cochrane review had strict selection criteria (diagnostic accuracy studies presenting data), 
our study selection was broader. We aimed to get a broader view by also exploring the origin of red flags 
and all kinds of supporting evidence to justify guideline recommendations. Our study supports the 
conclusions of the Cochrane review, hereby restating that the evidence for the use and 
recommendations of most red flags is very weak.  
Most guidelines infer that when red flags are present further investigation is warranted [8]. This advice 
is nevertheless heavily criticized for the high risk of a false positive finding [9]. In a primary care cohort 
of 1172 patients with LBP, most patients (80.4%) had at least 1 red flag [24]. Also in a study focussing on 
physiotherapist’s adherence to guidelines, the authors found that 7 of the 11 red flags were 
documented in 98% of the patients [44]. A web-based survey among adults with LBP confirmed these 
findings with 68.2% of the participants presenting at least 1 red flag [45].  
As most patients have at least 1 individual red flag present, and most individual red flags do not show 
acceptable high accuracy, an alternative strategy could be to focus on a combination of red flags in 
identifying patients with a higher likelihood of malignancies (ruling people in). The first attempt to 
develop such a risk model is made by Deyo & Diehl [20]. They found that a combination of ‘ESR rate > 
20mm/hour’ and ‘a history of cancer’ was both significant in a multivariate analysis, but this model still 
misclassified 6 out of 13 patients as having no malignancy while it was present.  
One study developed a hypothetical model for diagnosing malignancy in primary care patients with LBP 
based on decision analysis with incremental cost-effectiveness analysis using the 5 most relevant factors 
found by Deyo & Diehl [46]. The strategy with the highest specificity and lowest costs was to refer all 
people who have one or more of the following clinical findings (‘history of cancer’, ‘age > 50 years’, 
‘weight loss’, ‘failure to improve with treatment’) in combination with ‘an ESR rate > 50mm/hour’ or ‘a 
positive X-ray’ [46]. Unfortunately, this strategy still missed 2 patients with malignancy [Deyo 1988]. 
 
4.2. Strength and limitations 
The search strategy for this study was relatively broad, and we also included snowballing techniques, 
which meant that we started with reference and citation tracking of a land mark article, which is 
regarded a powerful strategy especially for finding papers in obscure locations [11]. Using this 
technique, we mainly found extra case studies. It is reassuring that all relevant studies, including 
diagnostic accuracy data, were found with the normal search strategy. Nevertheless, as most studies 
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were not designed as diagnostic accuracy studies, some potentially relevant studies may have been 
missed. In addition, data extraction was challenging and resulted in a few occasions in a different 
interpretation of the data compared to the systematic review [15]. Nevertheless, differences in data 
interpretation were small and did not affect our conclusions. 
We considered the low prevalence of malignancy in primary care patients with LBP in setting the 
threshold of an LR+ >15 as potentially clinical informative red flags. This means that when the red flag is 
present the probability of malignancy increases from 0.8% to around 10%, which we considered a 
reasonable increase, given the nature of the target condition. 
As diagnostic accuracy shows robust outcomes between various studies, we think our outcomes are 
generalizable to all different settings and populations. 
The lack of a precise definition of red flags highlights a barrier when determining which red flags may be 
clinically informative. For example, because of lack of definition, conflicting diagnostic accuracy data 
may be presented for the same red flag in similar clinical settings (e.g. strong clinical suspicion’). Also, 
concerning the red flag ‘history of malignancy’, the timing and clinical characteristics of previous 
malignancy might be important. The origin of this red flag comes from Thomas Luke in 1911 based on 
women with a history of breast cancer. None of the other studies provided clinical information on 
previous malignancy or the time elapsed between diagnosis of the previous malignancy and the current 
episode of back pain, which might influence the accuracy of this red flag. Similarly, potential overlap of 
red flags might be an additional barrier, as it is unclear whether ‘increasing pain at night’, pain not eased 
by a prone position’ and ‘continuous pain at rest’ are similar. 
 
4.3. Future direction 
Malignancy is a disease clinicians do not want to miss, but equally a clinician does not want to needlessly 
alarm their patients by sending patients off for a diagnostic work-up. Previous discussions on screening 
for malignancy in patients presenting with LBP have tended to promote the ideal of a highly sensitive 
test where a negative result can be used to ‘rule out’ malignancy. The limitations with this approach are 
that the pretest probability of malignancy is already very low and the use of a highly sensitive test will 
inevitably mean that most people who test positive will be false positives. The American College of 
Physicians Guideline on imaging for LBP offers an alternative approach. They suggest that when there is 
a weaker suspicion of malignancy, the clinician could consider initiating a trial of therapy and reviewing 
the patient in a timely fashion to ensure that recovery is occurring as expected. At present, we are 
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unaware of any research that has surveyed clinicians and patients about their views and preferences in 
this matter. This would seem an important area for future research. 
In addition, we suggest a (limited) core set of red flags, which could be evaluated in new high quality 
diagnostic accuracy studies and to start with a core set of 2 red flags that show to be promising in the 
current study. Developing a diagnostic (risk) model might result in better diagnostic accuracy. 
 
 
5. Conclusion   
For the majority of red flags for malignancy included in clinical guidelines, the origin is unclear and there 
is strikingly little or no evidence available regarding their diagnostic accuracy. Two red flags were 
evaluated in 2 diagnostic studies at low RoB and had acceptably high LR+ to guide decision making: 
‘history of malignancy’ and ‘strong clinical suspicion’. At present, these are the only red flags that have 
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Table 1: Red flags for malignancies 
Red flags 
Endorsed in number of 
guidelines) 
Prevalence  Setting  Identified as 
relevant in cohort 
studies or case 
series 
Diagnostic accuracy Risk of 
Bias 
Quality of the 
evidence 
(informativeneness) 
Se (95%CI) Sp (95%CI) 
History of malignancies/cancer (15) N/A Unknown Case series [Luke 1911, 
Thompson 1996] 
N/A  Moderate (informative) 
0.66% 
(13/1975) 
Primary care Prospective cohort [Deyo 
1988] 
31% (6 to 56) 98% (97 to 
99) 
Low risk 
0% (0/1172) Primary care Prospective cohort 
[Henschke 2009] 
 96% (95 to 
97) 
Low risk 
0.7% (5/638) Secondary 
care 
Prospective cohort [de 
Schepper 2016] 
20% (-15 to 
55) 
97% (96 to 
98) 
Low risk 




100%  Moderate 
risk 
(Unexplained/unintentional) 
Weight loss (12) 
0.66% 
(13/1975) 
Primary care Prospective cohort [Deyo 
1988] 
 
15% (-4 to 
35) 
94% (93 to 
95) 
Low risk Moderate 
(uninformative) 
0% (0/1172) Primary care Prospective cohort 
[Henschke 2009] 
 99.7% (99 to 
100) 
Low risk 
0.7% (5/638) Secondary 
care 
Prospective cohort [de 
Schepper 2016] 
0% (0 to 0) 88% (86 to 
91) 
Low risk 
Pain either increasing at night or at 
rest or pain at night that is not 
eased by a prone position (or 
increasing in supine position) (12) 
 
N/A Unknown Case series [Luke 1911, 
Thompson 1996] 
N/A  Very low 
(uninformative) 
0.7% (5/638) Secondary 
care 
Prospective cohort [de 
Schepper 2016] (low back 
pain at night) 
40% (-3 to 
83) 
47% (43 to 
50) 
Low risk 
Older age; either just older age or 
more specific over 50 years (7) 
N/A Tertiary care Case series [Thompson 
1996] 




Primary care Prospective cohort [Deyo 
1988] (age > 50 years) 
77% (54 to 
100) 
71% (69 to 
73) 
Low risk 
0% (0/1172) Primary care Prospective cohort 
[Henschke 2013] (age > 
55) 
 66% (63 to 
69) 
Low risk 
0.7% (5/638) Secondary 
care 
Prospective cohort [de 
Schepper 2016] (age > 50 
years) 
100% 77% (74 to 
80) 
Low risk 
1.45% (7/482) Emergency 
department 
Prospective cohort 
[Reinus 1998]*, (age > 50 





Endorsed in number of 
guidelines) 
Prevalence  Setting  Identified as 
relevant in cohort 
studies or case 
series 
Diagnostic accuracy Risk of 
Bias 
Quality of the 
evidence 
(informativeneness) 
Se (95%CI) Sp (95%CI) 
years) 
0.45% (2/471) Secondary 
care 
Retrospective cohort 
[Frazier 1989], (age > 50 
years) 
50% (-19 to 
119%) 
74% (70 to 
78) 
High risk  
Malaise (5) 
 
N/A Tertiary care Case series [Thompson 
1996] 
  NA 
Failure to improve with treatment 
(>4 – 6 weeks) / Seeking medical 
care last month (4) 
N/A  Case study [Pringle 2006, 
Mabry 2014] 




Primary care Prospective cohort [Deyo 
1988]  
31% (6 to 56) 90% (89 to 
91) 
Low risk 
0% (0/1172) Primary care Prospective cohort 
[Henschke 2009] 
 84% (81 to 
91) 
Low risk 
Strong clinical suspicion (1) (1/1030) Primary care Prospective cohort [Khoo 
2003] 





0% (0/1172) Primary care  Prospective cohort 
[Henschke 2009] 
 99.9% (99.9 
to 100) 
Low risk 








Fever (1) 0.66% 
(13/1975) 
 Prospective cohort [Deyo 
1988] 
 98% (97 to 
99) 
Low risk NA 
Reduced appetite (1) 
 
      
Rapid fatigue (1) 
 
      
Progressive symptoms (1) 
 
      
 
Red flags not endorsed in guidelines 
      
Multiple risk factors (1) 
 
       
Paraparesis (1)    )    
Duration of the complaint > 1 
month (0) 
N/A Tertiary care Case series [Thompson 
1996] 




Primary care Prospective cohort [Deyo 
1988] 
50% (22 to 
78) 






Endorsed in number of 
guidelines) 
Prevalence  Setting  Identified as 
relevant in cohort 
studies or case 
series 
Diagnostic accuracy Risk of 
Bias 
Quality of the 
evidence 
(informativeneness) 
Se (95%CI) Sp (95%CI) 
0% (0/1172) Primary care Prospective cohort 
[Henschke 2009] 




Se = sensitivity; sp = specificity; 95%CI = 95% confidence interval 
N/A = not applicable as study only included cases so prevalence could not be calculated 
  



































8 case reports 
Full text, n=63 
Excluded based 




Figure2: Risk of Bias assessment 
 
 
